Avalo Therapeutics Inc is a clinical-stage precision medicine company that discovers, develops, and commercializes targeted therapeutics for patients with significant unmet clinical needs in immunology, immuno-oncology, and rare genetic diseases. Its pipeline consists of product candidates advancing... Avalo Therapeutics Inc is a clinical-stage precision medicine company that discovers, develops, and commercializes targeted therapeutics for patients with significant unmet clinical needs in immunology, immuno-oncology, and rare genetic diseases. Its pipeline consists of product candidates advancing in development with ongoing clinical programs: AVTX-002, AVTX-007, and AVTX-006. 더 보기
Proceeds from the full exercise of warrants issued in the first quarter of 2024 private placement bring the total gross proceeds from the transaction to $185 millionCash runway expected into at...
WAYNE, Pa. and ROCKVILLE, Md., Nov. 11, 2024 (GLOBE NEWSWIRE) -- Avalo Therapeutics, Inc. (Nasdaq: AVTX), a clinical stage biotechnology company focused on the treatment of immune dysregulation...
기간 | 변동 | 변동 % | 시가 | 고가 | 저가 | 평균 일일 거래량 | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | -1.7 | -18.6199342826 | 9.13 | 9.41 | 7.36 | 72620 | 8.54359584 | CS |
4 | -2.56 | -25.6256256256 | 9.99 | 12 | 7.36 | 151382 | 9.22223298 | CS |
12 | -2.09 | -21.9537815126 | 9.52 | 16 | 7.36 | 85008 | 10.47285889 | CS |
26 | -5.21 | -41.2183544304 | 12.64 | 16 | 6.84 | 48257 | 10.34417899 | CS |
52 | -1.37 | -15.5681818182 | 8.8 | 34.46 | 3.9501 | 202557 | 17.66147018 | CS |
156 | -388.57 | -98.1237373737 | 396 | 1711.2 | 3.9501 | 7922775 | 35.81805354 | CS |
260 | -681.37 | -98.9213124274 | 688.8 | 1711.2 | 3.9501 | 7144460 | 39.29873338 | CS |
도움 및 지원받기: kr-support@advfn.com
ADVFN 서비스 이용은 ADVFN의 이용약관에 동의하는 것입니다 이용약관